|Daily Range||$95.98 - $99.98|
|52-Week Range||$59.05 - $116.65|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||915,039|
|Current FY EPS||$6.93|
How do you think UTHR
will perform against the market?
Top UTHR Bull/Bear Pitches
Turtlebale (< 20)
Submitted June 6, 2011
negative response to clinical data is an overreaction
Submitted October 4, 2006
New PAH drugs will reduce UTHR's market; generic Flolan, Ambrisentan etc.
News & Commentary
United Therapeutics Corp (UTHR) Description
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. Website: http://www.unither.com/